Today is 2020-09-23

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series
download

注册号:

Registration number:

ChiCTR2000033323 

最近更新日期:

Date of Last Refreshed on:

2020-05-28 

注册时间:

Date of Registration:

2020-05-28 

注册号状态:

预注册  

Registration Status:

Prospective registration  

注册题目:

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series 

Public title:

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series 

Scientific title:

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series 

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

Rawezh qadr 

研究负责人:

Fahmi Hussein Kakamad 

Applicant:

Rawezh qadr 

Study leader:

Fahmi Hussein Kakamad 

申请注册联系人电话:

Applicant telephone:

+96 477 17267454 

研究负责人电话:

Study leader's telephone:

+96 477 17267454 

申请注册联系人传真 :

Applicant Fax:

 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

Rawizh.mohammed94@gmail.com 

研究负责人电子邮件:

Study leader's E-mail:

Rawizh.mohammed94@gmail.com 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

Doctor city, Sulaimani, Iraq 

研究负责人通讯地址:

Doctor city, Sulaimani, Iraq 

Applicant address:

Doctor city, Sulaimani, Iraq 

Study leader's address:

Doctor city, Sulaimani, Iraq 

申请注册联系人邮政编码:

Applicant postcode:

 

研究负责人邮政编码:

Study leader's postcode:

 

申请人所在单位:

伊拉克苏莱曼尼大学 

Applicant's institution:

University of Sulaimani, Sulaimani, Iraq 

是否获伦理委员会批准:

是 

Approved by ethic committee:

Yes 

伦理委员会批件文号:

Approved No. of ethic committee:

233 

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Arabic board of medical specialties- Ethical committee 

Name of the ethic committee:

Arabic board of medical specialties- Ethical committee 

伦理委员会批准日期:

Date of approved by ethic committee:

 

伦理委员会联系人:

hiwa 

Contact Name of the ethic committee:

hiwa 

伦理委员会联系地址:

Doctor city, Sulaimani, Iraq 

Contact Address of the ethic committee:

Doctor city, Sulaimani, Iraq 

伦理委员会联系人电话:

Contact phone of the ethic committee:

+96 477 17267454 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

abdulwahid.salih@univsul.edu.iq 

研究实施负责(组长)单位:

None 

Primary sponsor:

none 

研究实施负责(组长)单位地址:

None 

Primary sponsor's address:

none 

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

None 

Source(s) of funding:

None 

研究疾病:

新型冠状病毒肺炎(COVID-19) 

Target disease:

Novel Coronavirus Pneumonia (COVID-19) 

研究疾病代码:

 

Target disease code:

 

研究类型:

干预性研究 

Study type:

Interventional study 

研究所处阶段:

其它 

Study phase:

N/A 

研究目的:

effect of convalescent plasma of COVID 

Objectives of Study:

effect of convalescent plasma of COVID 

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

研究设计:

连续入组 

Study design:

Sequential 

纳入标准:

COVID with convalescent plasma treatment 

Inclusion criteria

COVID with convalescent plasma treatment 

排除标准:

Non-covid patient 

Exclusion criteria:

Non-covid patient 

研究实施时间:

Study execute time:

From2020-05-11To 2020-05-19 

征募观察对象时间:

Recruiting time:

From2020-05-11To 2020-05-14 

干预措施:

Interventions:

组别:

Case series

样本量:

24

Group:

Case series

Sample size:

干预措施:

convalescent plasma of COVID

干预措施代码:

Intervention:

convalescent plasma of COVID

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

伊拉克 

省(直辖市):

苏莱曼尼 

市(区县):

 

Country:

Iraq 

Province:

Sulaimani 

City:

Sulaimani 

单位(医院):

苏莱曼尼大学 

单位级别:

大学 

Institution
hospital:

University of sulaimani  

Level of the institution:

University 

测量指标:

Outcomes:

指标中文名:

痊愈率

指标类型:

主要指标 

Outcome:

Rate of cure

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁 

说明

Fate of sample:

Destruction after use 

Note:

征募研究对象情况:

Recruiting status:

结束

Completed

年龄范围:

Participant age:

最小 Min age 45 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

点击下载

Calculated Results ater
the Study Completed(upload file):

download

原始数据公开时间:

The time of sharing IPD:

Real time access

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Not stated

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

N/A

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Not stated

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

N/A

数据管理委员会:

Data Managemen Committee:

有/Yes

注册人:

Name of Registration:

 2020-05-28
return list